PLSE (Pulse Biosciences, Inc Common Stock (DE)) Stock Analysis - Hedge Fund Holdings
Pulse Biosciences, Inc Common Stock (DE) (PLSE) is a publicly traded Healthcare sector company. As of May 21, 2026, PLSE trades at $25.66 with a market cap of $1.77B and a P/E ratio of -23.50. PLSE moved +4.49% today. Year to date, PLSE is +78.70%; over the trailing twelve months it is +52.84%. Its 52-week range spans $12.56 to $27.98. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces PLSE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns PLSE stock?
Hedge funds tracked by Rallies that own PLSE include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Pulse Biosciences, Inc Common Stock (DE).
PLSE Key Metrics
Key financial metrics for PLSE
Metric
Value
Price
$25.66
Market Cap
$1.77B
P/E Ratio
-23.50
EPS
$-1.10
Dividend Yield
0.00%
52-Week High
$27.98
52-Week Low
$12.56
Volume
0
Avg Volume
0
Revenue (TTM)
$751.00K
Net Income
$-74.57M
Gross Margin
0.00%
Top Hedge Funds Holding PLSE
Exoduspoint Capital holds 25.12K shares of PLSE, changed +14.90% as of Dec 31, 2025.
Hedge funds tracked by Rallies that own PLSE include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Pulse Biosciences, Inc Common Stock (DE).
Does Rallies show 13F holders for PLSE?
Yes. Rallies tracks hedge fund and 13F ownership data for PLSE, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PLSE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PLSE. It does not provide personalized investment advice.
